课题基金 / 基金详情

Ryanodine receptor as a novel therapeutic target of lethal arrhythmia

Ryanodine receptor as a novel therapeutic target of lethal arrhythmia
Ryanodine受体作为致命性心律失常的新治疗靶点
批准号:
18590777
负责人:
YAMAMOTO Takeshi
金额:
$2.55万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

YAMAMOTO Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We previously demonstrated that K201 (JTV5I9) inhibits the Call leak by correcting the defective inter-domain interaction between N-terminal (0-600) and central regions (2000-2500) of the ryanodine receptor (RyR2) in failing hearts. Here, we identified the K201-binding domain and characterized the role of this novel domain on RyR2 channel gating. An assay using a quartz-crystal microbalance technique revealed that K201 specifically bound to recombinant RyR2 fragment: 1741-2270, but not to other RyR2 fragments (-500 amino acid residues) from the 1-2750 region. By further analysis of the fragment^<1741-2270>, K201 was found to specifically bind to its sub-fragment^<2114-2149>. Using the peptide matching this sub-fragment (DP^<2114-2149>) as a carrier, the RyR2 was specifically labeled with methylcoumarin acetate (MCA). Moreover, of several recombinant RyR2 fragments (1-2750), only fragment^<2234-2750> was specifically MCA-labeled; this suggests that the K201 binding domain^<2114-2149> binds with domain^<2234-2750>. Addition of DP^<2114-2149> to the MCA-labeled SR interfered with the interaction between domain^<2114-2149> and domain^<2234-2750> causing domain unzipping, as evidenced by an increased accessibility of the bound MCA to a large-size fluorescence quencher. In failing cardiomyocytes (F; n=15), the frequency of spontaneous Ca^<2+> spark (CaSF: s-1.100μm-1) was markedly increased compared with normal (N; n=15) cardiomyocytes (F: 2.7±0.7, N: 0.9±0.4; p<0.01 vs N), whereas incorporation of DP^<2114-2149> markedly decreased CaSF (1.3±0.5, p<0.01 vs F), the same effect as that produced by K201. In conclusion, we first identified the K201-binding site as domain^<2114-2149> of RyR2. Interruption of the inter-domain interaction between the domain^<2114-2149> and central domain^<2234-2750> seems to mediate stabilization of RyR2 in failing hearts, which may lead to a novel therapeutic strategy against heart failure and perhaps lethal arrhythmia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in eart failure.
在心力衰竭中,低剂量卡维地洛清除自由基可通过稳定兰尼碱受体来防止氧化还原依赖性 Ca2+ 泄漏。
DOI: --
发表时间: 2007
期刊: J Am Coll Cardiol. 49
影响因子: --
作者: [Mochizuki M, et. al.]
通讯作者: et. al.
Marked Increase in Spontaneous Ca2+Sparks in Response to b-stimulation as a Critical Cause of Catecholaminergic Polymorphic Ventricular Tachycardia
b 刺激引起的自发 Ca2 火花显着增加是儿茶酚胺能多形性室性心动过速的关键原因
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Mochizuki, M, et. al., 望月 守, 望月守, 山本 健]
通讯作者: 山本 健
DOI: 10.1161/circulationaha.107.718957
发表时间: 2008-02-12
期刊: CIRCULATION
影响因子: 37.8
作者: [Yamamoto, Takeshi, Yano, Masafumi, Matsuzaki, Masunori]
通讯作者: Matsuzaki, Masunori
DOI: 10.1016/j.jacc.2007.01.064
发表时间: 2007-04-24
期刊: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
影响因子: 24
作者: [Mochizuki, Mamoru, Yano, Masafumi, Matsuzaki, Masunori]
通讯作者: Matsuzaki, Masunori
Toward the integration of segment weight and sonority
Novel therapy of arrhythmia targeting key domain in ryanodine receptor
  • 批准号:
    15K09085
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2015
  • 负责人:
    YAMAMOTO Takeshi
  • 依托单位:
Visions of the End of the Cold War in Europe during the late 1970s
  • 批准号:
    25780119
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $1.25万
  • 财政年份:
    2013
  • 负责人:
    YAMAMOTO Takeshi
  • 依托单位:
A comprehensive study on English syllables
国内基金
海外基金
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    张明明
  • 依托单位:
钙信号负向调节因子IRBIT抑制肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    31960151
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    40.0万元
  • 批准年份:
    2019
  • 负责人:
    徐靖宇
  • 依托单位:
基于钙信号特征机制的肿瘤转移调控研究
  • 批准号:
    31970729
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    魏朝亮
  • 依托单位:
一种拟南芥IP3结合蛋白作用机制及功能研究
  • 批准号:
    31970723
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2019
  • 负责人:
    韩生成
  • 依托单位: